TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QDEL

Quidel Corporation

Healthcare · Medical Devices

13.80$ +2.8% vs. previous close Closing price · As of: Aug 19, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Quidel Corporation (QDEL). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — QDEL
Segment 2020 2021 2022 2023 2024 2025
North America $1.46B 87.9% $1.50B 88.3% · +2.7% $2.54B 77.7% · +69.1% $1.88B 62.6% · -26.0% $1.62B 58.2% · -13.7% $1.49B 54.5% · -8.1%
EMEA $92.9M 5.6% $69.6M 4.1% · -25.1% $206.8M 6.3% · +197.1% $327.3M 10.9% · +58.3% $335.8M 12.1% · +2.6% $360.7M 13.2% · +7.4%
China $310.1M 10.3% $325.0M 11.7% · +4.8% $334.7M 12.3% · +3.0%
JPAC $272.7M 9.1% $279.4M 10.0% · +2.5% $293.0M 10.7% · +4.9%
Latin America $210.6M 7.0% $222.9M 8.0% · +5.8% $252.9M 9.3% · +13.5%
China $62.4M 3.8% $58.0M 3.4% · -7.1% $220.0M 6.7% · +279.3%
Other $45.7M 2.8% $70.8M 4.2% · +54.9% $302.7M 9.3% · +327.5%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by region

Revenue by region — QDEL
Segment 2020 2021 2022 2023 2024 2025
Domestic $1.45B 87.4% $1.42B 83.3% · -2.5% $2.45B 75.1% · +73.2% $1.83B 61.0% · -25.4% $1.57B 56.4% · -14.2% $1.44B 52.6% · -8.4%
Foreign $209.3M 12.6% $283.1M 16.7% · +35.3% $814.3M 24.9% · +187.6% $1.17B 39.0% · +43.5% $1.21B 43.6% · +3.9% $1.29B 47.4% · +6.5%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?